Russell Investments Group Portfolio holdings
AUM
$78.5B
1-Year Return
23.79%
This Quarter Return
+3.31%
1 Year Return
+23.79%
3 Year Return
+95.55%
5 Year Return
+186.04%
10 Year Return
–
AUM
$62.1B
AUM Growth
-$1.31B
(-2.1%)
Cap. Flow
-$2.35B
Cap. Flow
% of AUM
-3.79%
Top 10 Holdings %
Top 10 Hldgs %
23.01%
Holding
3,689
New
360
Increased
1,515
Reduced
1,399
Closed
93
Top Buys
| 1 |
Apple
AAPL
|
+$185M |
| 2 |
Philip Morris
PM
|
+$61.3M |
| 3 |
Exxon Mobil
XOM
|
+$56.4M |
| 4 |
Xcel Energy
XEL
|
+$38.9M |
| 5 |
Crown Castle
CCI
|
+$38.8M |
Top Sells
| 1 |
Microsoft
MSFT
|
+$176M |
| 2 |
TSMC
TSM
|
+$120M |
| 3 |
NVIDIA
NVDA
|
+$106M |
| 4 |
Equinix
EQIX
|
+$97.8M |
| 5 |
Meta Platforms (Facebook)
META
|
+$92.2M |
Sector Composition
| 1 | Technology | 25.94% |
| 2 | Financials | 12.31% |
| 3 | Healthcare | 10.81% |
| 4 | Consumer Discretionary | 10.14% |
| 5 | Real Estate | 8.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3001
Nabors Industries
NBR
$619M
| $8.68K | ﹤0.01% |
122
-642
| -84% | -$45.7K |
|
3002
Fresenius Medical Care
FMS
$14.6B
| $8.59K | ﹤0.01% |
450
+438
| +3,650% | +$8.36K |
|
3003
Rallybio
RLYB
$25.1M
| $8.56K | ﹤0.01% |
6,390
+2,345
| +58% | +$3.14K |
|
3004
Value Line
VALU
$359M
| $8.53K | ﹤0.01% |
198
+195
| +6,500% | +$8.4K |
|
3005
Mural Oncology
MURA
$35.9M
| $8.52K | ﹤0.01% |
2,713
+1,554
| +134% | +$4.88K |
|
3006
Solid Power
SLDP
$645M
| $8.5K | ﹤0.01% |
5,150
+4,890
| +1,881% | +$8.07K |
|
3007
Grindr
GRND
$2.96B
| $8.48K | ﹤0.01% |
693
+422
| +156% | +$5.17K |
|
3008
TTEC Holdings
TTEC
$179M
| $8.47K | ﹤0.01% |
1,440
+1,243
| +631% | +$7.31K |
|
|
HCP
3009
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $8.46K | ﹤0.01% |
251
+170
| +210% | +$5.73K |
|
3010
Immuneering
IMRX
$338M
| $8.44K | ﹤0.01% |
+6,594
| New | +$8.44K |
|
3011
SoundHound AI
SOUN
$5.73B
| $8.43K | ﹤0.01% |
+2,133
| New | +$8.43K |
|
3012
Invesco S&P 500 Pure Value ETF
RPV
$1.34B
| $8.34K | ﹤0.01% |
+100
| New | +$8.34K |
|
3013
Spero Therapeutics
SPRO
$109M
| $8.32K | ﹤0.01% |
6,400
| – | – |
|
3014
Workhorse Group
WKHS
$17.8M
| $8.29K | ﹤0.01% |
+422
| New | +$8.29K |
|
3015
Albany International
AIN
$1.77B
| $8.29K | ﹤0.01% |
98
-2,780
| -97% | -$235K |
|
|
NXDT
3016
NexPoint Diversified Real Estate Trust
NXDT
$176M
| $8.22K | ﹤0.01% |
1,487
+1,090
| +275% | +$6.03K |
|
3017
Kimbell Royalty Partners
KRP
$1.29B
| $8.18K | ﹤0.01% |
500
| – | – |
|
3018
Riley Exploration Permian
REPX
$619M
| $8.15K | ﹤0.01% |
288
-4,283
| -94% | -$121K |
|
3019
C3.ai
AI
$2.15B
| $8.14K | ﹤0.01% |
281
+23
| +9% | +$666 |
|
3020
ProKidney
PROK
$292M
| $8.14K | ﹤0.01% |
3,308
+2,465
| +292% | +$6.06K |
|
|
RERE
3021
ATRenew
RERE
$928M
| $8.13K | ﹤0.01% |
+3,697
| New | +$8.13K |
|
|
VIGL
3022
DELISTED
Vigil Neuroscience
VIGL
| $8.12K | ﹤0.01% |
+2,029
| New | +$8.12K |
|
3023
John Marshall Bancorp
JMSB
$286M
| $8.11K | ﹤0.01% |
+465
| New | +$8.11K |
|
3024
Sangamo Therapeutics
SGMO
$160M
| $8.09K | ﹤0.01% |
22,577
+16,299
| +260% | +$5.84K |
|
3025
LCNB Corp
LCNB
$227M
| $8.07K | ﹤0.01% |
+580
| New | +$8.07K |
|